Join the club for FREE to access the whole archive and other member benefits.

Michael Ringel

Managing Director and Senior Partner at Boston Consulting Group

Michael Ringel is Boston Consulting Group's global leader for innovation analytics and research and product development. He is a core member of BCG’s Corporate Finance & Strategy practice and has been with the firm since 1999. Over his career, Michael has advised biotech and pharmaceutical clients on critical areas such as disease area strategy, process optimization, sourcing, partnerships, and organization design. He also has expertise in mergers and acquisitions, licensing, and post-merger integration.

Michael is a frequent contributor to industry publications like Nature Reviews Drug Discovery and has coauthored numerous BCG reports on innovation, R&D, and corporate strategy. Additionally, he serves on the board of The Nature Conservancy in Massachusetts. Before joining BCG, Michael conducted academic research on population dynamics and performed fieldwork in the Amazon basin near Manaus, Brazil.

Visit website: https://www.bcg.com/about/people/experts/michael-ringel

 michael-ringel-b272a2

 M_S_Ringel

See also

Boston Consulting Group

Business strategy and management

Details last updated 16-Oct-2024

Michael Ringel is also referenced in the following:

Aging Code Summit

11-Jun-2025

Summit exploring the Aging Code through AI organised by Longevity Global (Cambridge, MA, USA)

D.C. Summit 2025

28-Apr-2025

The Second Annual Alliance for Longevity Initiatives summit (Washington, D.C., USA)

Global Healthspan Summit (GHS) 2025

04-Feb-2025

Longevity summit organised by Hevolution Foundation (Riyadh,Saudi Arabia)

Longevity Summit Dublin 2025

02-Jul-2025

The aim is to explore a crucial question: What does the future of ageing look like? (Dublin, Ireland)

Surging Investment in Longevity & Geroscience - Michael Ringel at Longevity Summit Dublin 2024

Michael Ringel delivered a keynote on the surging investment in longevity and geroscience